Cargando…
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the National Kidney Foundation, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137360/ https://www.ncbi.nlm.nih.gov/pubmed/34023417 http://dx.doi.org/10.1053/j.ajkd.2021.05.006 |
| _version_ | 1783695608042749952 |
|---|---|
| author | Komaba, Hirotaka Wada, Takehiko Fukagawa, Masafumi |
| author_facet | Komaba, Hirotaka Wada, Takehiko Fukagawa, Masafumi |
| author_sort | Komaba, Hirotaka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8137360 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | by the National Kidney Foundation, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81373602021-05-21 Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine Komaba, Hirotaka Wada, Takehiko Fukagawa, Masafumi Am J Kidney Dis Correspondence by the National Kidney Foundation, Inc. 2021-09 2021-05-21 /pmc/articles/PMC8137360/ /pubmed/34023417 http://dx.doi.org/10.1053/j.ajkd.2021.05.006 Text en © 2021 by the National Kidney Foundation, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Komaba, Hirotaka Wada, Takehiko Fukagawa, Masafumi Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine |
| title | Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine |
| title_full | Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine |
| title_fullStr | Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine |
| title_full_unstemmed | Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine |
| title_short | Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine |
| title_sort | relapse of minimal change disease following the pfizer-biontech covid-19 vaccine |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137360/ https://www.ncbi.nlm.nih.gov/pubmed/34023417 http://dx.doi.org/10.1053/j.ajkd.2021.05.006 |
| work_keys_str_mv | AT komabahirotaka relapseofminimalchangediseasefollowingthepfizerbiontechcovid19vaccine AT wadatakehiko relapseofminimalchangediseasefollowingthepfizerbiontechcovid19vaccine AT fukagawamasafumi relapseofminimalchangediseasefollowingthepfizerbiontechcovid19vaccine |